Adaptive response induced by lipid peroxidation products in cell cultures  by Chen, Zhi-Hua et al.
FEBS Letters 580 (2006) 479–483Adaptive response induced by lipid peroxidation products in cell cultures
Zhi-Hua Chena,*, Yasukazu Yoshidaa, Yoshiro Saitoa, Noriko Noguchib,c, Etsuo Nikia
a Human Stress Signal Research Center (HSSRC), National Institute of Advanced Industrial Science and Technology (AIST),
1-8-31, Midorigaoka, Ikeda, Osaka 563-8577, Japan
b Research Center for Advanced Science and Technology, University of Tokyo, 4-6-1, Komaba, Tokyo 153-8904, Japan
c Science and Engineering Research Institute, Doshisha University, 1-3 Miyakotani, Tatara, Kyotanabe, Kyoto 610-0394, Japan
Received 20 October 2005; revised 28 November 2005; accepted 16 December 2005
Available online 22 December 2005
Edited by Vladimir SkulachevAbstract The adaptive response induced by the lipid peroxida-
tion products, such as phosphatidylcholine hydroperoxide, lyso-
phosphatidylcholine (LysoPC), 15-deoxy-D12,14-prostaglandin
J2, 4-hydroxynonenal (4-HNE), hydroxyoctadecadienoic acid,
7-hydroxycholesterol, and cholesterol 5b,6b-epoxide, was inves-
tigated in this study. Although these products have been impli-
cated in oxidative stress-related diseases, pretreatment with
such compounds at sublethal concentrations signiﬁcantly pro-
tected PC12 cells against subsequent oxidative stress induced
by 6-hydroxydopamine. Moreover, 4-HNE and LysoPC also
exhibited adaptive protection in human arterial endothelial cells.
These ﬁndings suggest a general hormetic eﬀect of such
compounds in cell cultures and may lead to a reappraisal of the
eventual role of reactive oxygen species and lipid peroxidation
in organisms.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The generation of reactive oxygen species (ROS) and subse-
quent oxidative modiﬁcation of biomolecules, such as lipids,
proteins, and nucleic acids, are inevitable in aerobic organisms.
An excessive amount of ROS, referred to as oxidative stress,
has been implicated in a variety of pathological events such
as atherosclerosis, ischemia-reperfusion injury, cardiovascular
diseases, and neurodegenerative diseases [1]. Above all, lipid
peroxidation has received much attention and has been ac-
cepted to cause disturbance of ﬁne structure and functional
loss of biological membranes and to produce some toxic
products.Abbreviations: b-EPOX-Ch, cholesterol 5b,6b-epoxide; 15d-PGJ2, 15-
deoxy-D12,14-prostaglandin J2; 4-HNE, 4-hydroxynonenal; HODE,
hydroxyoctadecadienoic acid; LysoPC, lysophosphatidylcholine;
7-OHCh, 7-hydroxycholesterol; 6-OHDA, 6-hydroxydopamine;
PCOOH, phosphatidylcholine hydroperoxide; ROS, reactive oxygen
species
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doi:10.1016/j.febslet.2005.12.045Phosphatidylcholine hydroperoxide (PCOOH) is the
primary product of lipid peroxidation, which undergoes
non-enzymatic reactions, leading to the formation of
4-hydroxynonenal (4-HNE) and malondialdehyde, secondary
products of lipid peroxidation [2,3]. Alternatively, the lipid
hydroperoxides, especially linoleic acid hydroperoxide, can
also be oxidized enzymatically by some peroxygenases and
reductases into hydroxyoctadecadienoic acids (HODEs)
[4,5]. Lysophosphatidylcholine (lysoPC) is generated from
phosphatidylcholine during oxidative modiﬁcation of low
density lipoprotein (LDL) [6,7]. Prostaglandins of the J series
are cyclopentenones synthesized from arachidonic acid via
enzymatic conversion by cyclooxygenase and prostaglandin
D2 synthase, followed by the non-enzymatic dehydration
from prostaglandin D2 to the J series, including 15-deoxy-
D12,14-prostaglandin J2 (15d-PGJ2) [8]. Oxysterols are deﬁned
as oxygenated derivatives of cholesterol that may be formed
directly by autoxidation or by the action of a speciﬁc mono-
oxygenase [9].
It is widely accepted that all these lipid peroxidation prod-
ucts mentioned above could induce oxidative stress and be in-
volved in the pathogenesis of a number of degenerative
diseases [10–13], or have been considered as biomarkers of oxi-
dative stress [14]. However, recent studies have revealed that
low levels of ROS and certain lipid oxidation products may
play essential roles in the cell signal transduction [15,16] and
can induce adaptive response [17–23]. We were therefore inter-
ested in studying whether these physiologically existed lipid
peroxidation products could also induce adaptive response at
low concentrations. We have recently found that stimulation
with sublethal concentrations of H2O2 or 4-HNE can induce
adaptive response and protect neural PC12 cells against the
subsequent oxidative stress [19,24], whereas little is known
about the possible adaptive eﬀect induced by others of these li-
pid peroxidation products. Therefore, in the present study, in
order to explore the generality of this phenomenon, we at-
tempted to examine the possible adaptive response to these li-
pid peroxidation products in neuronal PC12 cells. We found
that stimulation of PC12 cells with these compounds at suble-
thal concentrations induced adaptive response and protected
cells against the subsequent oxidative stress induced by 6-
hydroxydopamine (6-OHDA) , which has been demonstrated
to induce oxidative damage in neural system and implicated
in neurodegenerative disorders [25]. The possible adaptive re-
sponse induced by 4-HNE and lysophosphatidylcholine (Ly-
soPC) in human arterial endothelial cells (HAECs) has also
been investigated.blished by Elsevier B.V. All rights reserved.
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2.1. Materials
LysoPC was purchased from Wako, Osaka, Japan. 4-HNE and
15d-PGJ2 were from Calbiochem. Co., CA, USA. Authentic 7a- and
7b-hydroxycholesterol (OHCh) were obtained from Steraloids Inc.,
Newport, RI, USA. 9-EE-, 9-EZ-, 13-EE-HODE were products of
Cayman Chemical Company, MI, USA. PCOOH was a kind gift from
Dr. Takahashi in Hokkaido Pharmaceutical University. 6-OHDA and
cholesterol 5b,6b-epoxide (b-EPOX-Ch) were obtained from Sigma
Chemical Company. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) was from Dojindo Kumamoto, Japan. 2 07 0-
Dochloroﬂuorexcin diacetate (DCFH-DA) was purchased from
Molecular Probes (Eugene, OR, USA). All other chemicals were of
the highest quality commercially available.
2.2. Cell culture and determination of cell viability
PC12 cells were routinely cultured in DMEM/F-12 medium with L-
glutamine, sodium bicarbonate and pyridoxine hydrochloride, supple-
mented with 10% fetal bovine serum and 5% horse serum. HAECs
were cultured in EBM-2 medium containing 2% (v/v) fetal bovine ser-
um, 10 ng/mL human epidermal growth factor, 5 ng/mL ﬁbroblast
growth factor, 10 lg/mL heparin, 1 lg/mL hydrocortisone, 50 lg/mL
gentamycin and 50 ng/mL amphotericin B according to the manufac-
turer’s instruction. Both cell cultures were maintained at 37 C in a
humidiﬁed atmosphere of 5% CO2.
For determination of the cell viability, the conventional MTT reduc-
tion assay was used. The treated cells were incubated with 0.5 mg/ml
MTT at 37 C for 1 h. Isopropyl alcohol containing 0.04 N HCl was
added to the culture medium (3:2 by volume) and mixed with a pipette
until the formazan was completely dissolved. The optical density of
formazan was measured at 570 nm using a Multiskan Ascent plate
reader (Thermo Labsystems, Helsinki, Finland).
For the adaptive response study, cells were pretreated with sublethal
concentrations of oxidative stimuli for 24 h. The culture medium was
then removed and fresh medium containing diﬀerent concentrations
of second stressors was added into the cell cultures. The cells were then
incubated for additional 24 h and followed with the MTT assay to
check the cell viability.
2.3. Determination of intracellular ROS
Intracellular ROS were detected using DCFH-DA, as described pre-
viously [19]. Following treatment and DCFH-DA staining, cells were
excited with a 488 nm argon ion laser in a Cytomics FC500 Flow
Cytometry system and DCF emission was recorded at 525 nm. Data
were collected from at least 10000 events.
2.4. Statistics
All data of at least three independent experiments are expressed as
means ± S.D. and analyzed by the Student’s t test. Values of
P < 0.05 were considered to be statistically signiﬁcant.0 50 100 150 200
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Fig. 1. Cytotoxicity induced by lipid peroxidation products in PC12
cells. Cells were treated with each compound at various concentrations
for 24 h, and the cell viability was determined by MTT assay as
described in Section 2.3. Results
3.1. Cytotoxicity induced by various lipid peroxidation products
in PC12 cells
In order to explore the possible adaptive response by these
lipid peroxidation products, the cytotoxicity induced by such
compounds was ﬁrst investigated in PC12 cells. As shown in
Fig. 1, all listed compounds induced signiﬁcant cell death at
high concentrations, whereas the three isomers of HODE at
concentrations till 50 lM did not exhibit any cytotoxicity (data
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Fig. 2. Adaptive response induced by various kinds of lipid peroxi-
dation products in PC12 cells. (A) Adaptive cytoprotection induced by
primary lipid peroxidation products, LysoPC and PCOOH at suble-
thal concentrations. (B) Adaptive cytopretection induced by the
further degenerated lipid peroxidation products, HODE and 15d-
PGJ2 at sublethal concentrations. (C) Adaptive protection induced by
oxysterols, 7a-OHCh, 7b-OHCh and b-EPOX-Ch at sublethal con-
centrations. PC12 cells were pretreated with or without these lipid
peroxidation products for 24 h, and followed by the treatment with
various concentrations of 6-OHDA for an additional 24 h. \Signiﬁ-
cantly diﬀerent from the corresponding value without pretreatment
(P < 0.05).
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products in PC12 cells
We then studied the possible adaptive response induced by
these lipid peroxidation products. Based on the above ﬁndings,
the corresponding sublethal concentrations at which the lipid
peroxidation product did not induce any cytotoxicity were
then selected for studying the possible adaptive response in-
duced by this compound. The pretreatment of PC12 cells with
sublethal concentrations of 15d-PGJ2 or 7a-OHCh signiﬁ-
cantly protected cells against the cytotoxicity induced by them-
selves (data not shown), suggesting an adaptive response was
induced by these oxidative stimuli. Furthermore, pretreatment
of PC12 cells with the primary lipid peroxidation products, Ly-
soPC (125 lM) or PCOOH (10 lM) (Fig. 2A), or further
degenerated lipid peroxidation products, HODE (50 lM) or
15d-PGJ2 (7.5 lM) (Fig. 2B), or oxysterols, 7-hydroxycholes-
terol (7-OHCh, 20 lM) or b-EPOX-Ch (15 lM) (Fig. 2C),
for 24 h signiﬁcantly protected cells against the cytotoxicity in-
duced by 6-OHDA.
3.3. Intracellular ROS accumulation induced by 6-OHDA was
eﬀectively attenuated by the lipid peroxidation products at
their adaptive concentrations
The levels of ROS accumulation reﬂect the intracellular
redox status. We then investigated the possible eﬀect of these
lipid peroxidation products on the basal level and the
6-OHDA-induced accumulation of ROS. Pretreatment of
these lipid peroxidation products at sublethal concentrations
did not cause any appreciable variation on the basal level of
ROS (data not shown), however, the pretreatment eﬀectively
attenuated the ROS accumulation induced by 6-OHDA
(Fig. 3). In the unpretreated cells, incubation of 50 lM
6-OHDA for 6 h signiﬁcantly induced the ROS accumulation
till approximately 2.5-fold, which was eﬀectively attenuated,
even completely abolished, by the pretreatment of sublethal
lipid peroxidation products, suggesting the cellular antioxidant0
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Fig. 3. Pretreatment of the sublethal concentration of lipid peroxidation prod
PC12 cells. Cells were pretreated with or without the lipid peroxidation produ
additional 6 h. Cells were then stained with 5 lMDCFH-DA for 30 min and
diﬀerent from the value of control (P < 0.05). #Signiﬁcantly diﬀerent from thcapacity was enhanced by the pretreatment of these lipid
peroxidation products.
3.4. Adaptive response induced by 4-HNE and LysoPC in
HAECs
In order to study whether these lipid peroxidation products
could also induce adaptive eﬀect in endothelial cells, we then
investigated the possible adaptive response in HAECs. As
shown in Fig. 4, both 4-HNE and LysoPC at concentrations
higher than 5 lM induced signiﬁcant cell death (Fig. 4A),
and pretreatment with either of these compounds at 5 lM
for 24 h signiﬁcantly protected HAECs against the cytotoxicity
induced by 7b-OHCh (Fig. 4B), which has been demonstrated
to be involved in coronary artery disease [13].4. Discussion
It has been widely accepted that low levels of H2O2 and re-
lated ROS play essential roles in the cell signal transduction
[16] and can induce adaptive response [17–22]. Such roles of
some other physiological oxidative stimuli or oxidation prod-
ucts in modulating and participating in signal transduction
have received increased attention. For instance, 4-HNE, one
of the major end products of lipid peroxidation and previously
known as an oxidative agent, now has been recognized as a sig-
naling molecule at low concentrations and considered to
bridge the ﬁelds of oxidative stress and redox signaling
[24,26,27]. Likewise, cyclopentenone prostaglandins, which
have shown the proapoptotic eﬀect in a variety of cell types,
now have been reported to exert protective eﬀect at low con-
centrations via diﬀerent mechanisms [28–30]. In the present
study, we clearly demonstrated that other lipid peroxidation
products, such as LysoPC, PCOOH, 7-OHCh, b-EPOX-Ch
and HODE, could also induce adaptive response at sublethal
concentrations, protecting PC12 cells against the subsequent7α
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harvested for the ROS analysis, as described in Section 2. \Signiﬁcantly
e corresponding value without pretreatment (P < 0.05).
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Fig. 4. Adaptive cytoprotection induced by 4-HNE or LysoPC in
HAECs. (A) Cytotoxicity induced by 4-HNE or LysoPC in HAECs.
Cells were treated with 4-HNE or LysoPC at various concentrations for
24 h. (B) Adaptive protection induced by 4-HNE or LysoPC at
sublethal concentration. HAECs were pretreated with or without 4-
HNE or LysoPC for 24 h, and followed by the incubation with various
concentrations of 7b-OHCh for an additional 24 h. \Signiﬁcantly
diﬀerent from the corresponding value without pretreatment (P < 0.05).
482 Z.-H. Chen et al. / FEBS Letters 580 (2006) 479–483oxidative stress induced by 6-OHDA. Moreover, LysoPC and
4-HNE also exhibited adaptive response against the oxidative
cell death induced by 7b-OHCh in HAECs, indicating an
extensive possibility of such an adaptive eﬀect in diﬀerent cell
types and tissues.
The detailed molecular mechanisms for such an adaptive
response might be speciﬁc to a given cell type as well as to a
given stimulus. For example, it has been reported that H2O2-
induced adaptive response was mediated through either
increased catalase and glutathione peroxidase (GPx) activities
in PC12 cells [19], or enhanced catalase, GPx, and CuZnSOD
activities in human retinal pigment epithelium cells [20], or ele-
vated GSH contents in mycocardial cells [21], or upregulated
thioredoxin-1 in human umbilical vein endothelial cells [22].
We have recently reported that 4-HNE-induced adaptive re-
sponse in PC12 cells was critically mediated through induction
of thioredoxin reductase-1 (TR-1) via transcriptional activa-
tion of Nrf2 [24]. Interestingly, other lipid peroxidation prod-
ucts, such as LysoPC, 7-OHCh, PCOOH and HODE, did not
induce any considerable TR-1 expression at the adaptive con-
centrations (data not shown). Furthermore, we have recently
found that both 7-OHCh and 15d-PGJ2 induced signiﬁcant
elevation of the cellular GSH in PC12 cells and this increase
might be responsible for the adaptive cytoprotection, whereas
LysoPC, PCOOH, b-EPOX-Ch and HODE did not exert any
eﬀect on the GSH level (Chen et al., unpublished data). All
these ﬁndings suggest, in addition to TR1 and GSH, other cel-lular antioxidative events may also be involved in the adaptive
response, although the eventual role of which proteins or en-
zymes in the adaptive response needs to be further investi-
gated.
This extensively-existed adaptive response by a variety of
oxidative stimuli in various cell types may lead us to rethink
the role of ROS and lipid peroxidation products in cells. Such
a hormetic eﬀect may also require a reappraisal of the func-
tions of ROS and subsequent lipid peroxidation in organisms.
Based on the present study and other previous reports, it
would be quite reasonable to assume that so-called oxidative
stress at the controlled or mild levels may act as a good stress,
‘‘eustress’’. It would be also rational to assume that, at initial
time of oxidative stress, accumulation of lipid peroxidation
products serves as a feedback which stimulates the defense net-
work and transmits a SOS signal, thereby triggering the early-
response enzymes or proteins to cope with the forthcoming
oxidative disaster.
In conclusion, the present study clearly shows that various
lipid peroxidation products at sublethal concentrations induce
adaptive response and enhance cell tolerance. Cells treated
with these compounds exhibit higher resistance to oxidative
stress, although the detailed underlying molecular mechanisms
need to be further examined. These results represent an initial
eﬀort to demonstrate the possible adaptive eﬀect of the lipid
peroxidation products at sublethal concentrations, which
may lead to a reappraisal of the eventual role of ROS and lipid
peroxidation in organisms.References
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